Aclaris Therapeutics (ACRS) P/E (2015 - 2026)
Aclaris Therapeutics (ACRS) P/E from Oct 7, 2015 to Jul 21, 2026. The TTM Aclaris Therapeutics (ACRS) P/E is -9.75. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Aclaris Therapeutics (ACRS)
| Year | P/E | Change |
|---|---|---|
| 2026 | -9.75 | +88.18% |
| 2025 | -5.18 | +191.12% |
| 2024 | -1.78 | +182.13% |
| 2023 | -0.63 | -94.86% |
| 2022 | -12.27 | +32.17% |
| 2021 | -9.28 | +69.96% |
| 2020 | -5.46 | +1027.89% |
| 2019 | -0.48 | -73.93% |
| 2018 | -1.86 | -84.43% |
| 2017 | -11.93 | -13.12% |
| 2016 | -13.74 | +66.75% |
| 2015 | -8.24 | N/A |
Comparison Aclaris Therapeutics (ACRS) P/E with competitors
Aclaris Therapeutics (ACRS) P/E is -9.75.